PARIS: A French court on Wednesday allowed a class-action lawsuit to go ahead against pharmaceutical giant Sanofi by families of victims of Depakine, an epilepsy drug that can severely damage foetal development.
A class action initiated in 2017 by the Apesac association alleged that Sanofi did not inform patients early enough about the risks of birth defects and slowed development in children whose mothers were prescribed the drug during pregnancy. With the ruling the court opened the door to France's first class-action suit in the health sector, following a 2016 change in the law which previously allowed such action only against consumer goods companies.Based on medical knowledge at the time, Sanofi should have warned patients about congenital malformations from 1998 onwards and about neuro-developmental issues - which were less well understood previously - from 2001.
Law Law Latest News, Law Law Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: asiaonecom - 🏆 10. / 59 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »